Benzinga | May 11, 2021 07:54AM EDT

Fusion Pharmaceuticals Q1 EPS $(0.42) Up From $(6.01) YoY

Fusion Pharmaceuticals (NASDAQ:FUSN) reported quarterly losses of $(0.42) per share. This is a 93.01 percent increase over losses of $(6.01) per share from the same period last year.